FCM
BBNX

Farallon Capital Management’s Beta Bionics, Inc. Common Stock BBNX Stock Holding History

Farallon Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$61.2M Buy
4,203,920
+871,700
+26% +$12.7M 0.26% 47
2025
Q1 		$40.8M Buy
+3,332,220
New +$40.8M 0.2% 56